Results 181 to 190 of about 611,895 (310)
Resilience of recombinant antibiotic resistance gene-containing plasmids against common cell culture disposal methods. [PDF]
Gluth A, Zmasek C, Chiu S, Moon TS.
europepmc +1 more source
Recombinant DNA Research: Proposed Actions Under the Guidelines
National Institutes of Health [NIH] (United States). Office of Recombinant DNA Activities
core
This study presents a 3D embedded bioprinting platform that recapitulates key stromal features of the tumor microenvironment using fibroblasts and lung‐derived ECM. The model enables functional assessment of CAR‐NK cells and provides a versatile tool to support the development of next‐generation immunotherapeutic strategies against solid tumors ...
Dahong Kim +10 more
wiley +1 more source
CpxR and LrhA coordinate the regulation of Xenocoumacin 1 biosynthesis, flagellar assembly, and chemotaxis in <i>Xenorhabdus nematophila</i>. [PDF]
Han Y +9 more
europepmc +1 more source
Recombinant DNA Advisory Committee (minutes of meeting 6 October 1989)
National Institutes of Health [NIH] (United States). Recombinant DNA Advisory Committee
core
UCHL3 Regulates Subgenomic Flaviviral RNA Condensates to Promote Virus Propagation
ABSTRACT Flavivirus subgenomic RNAs (sfRNAs) antagonise antiviral defences, yet how sfRNAs are organized and maintained in cells remains poorly understood. Here we identify ubiquitin C‐terminal hydrolase L3 (UCHL3) as a post‐translational regulator of flavivirus sfRNA stability and function.
Oscar Trejo‐Cerro +7 more
wiley +1 more source
The Vaginal <i>Lactobacillus gasseri</i> YS1021 Effectively Degraded Mucin by Enzymolysis of M13 Metallopeptidase. [PDF]
Hou J +5 more
europepmc +1 more source
National Institute of General Medical Sciences (United States). Office of Recombinant DNA Activities
core
Enhancing CAR‐T Cell Efficacy in Solid Tumors by Inhibiting CCL5/VEGF‐Mediated Angiogenesis
This study reveals that CAR‐T cells in solid tumors produce CCL5, which paradoxically induces VEGF and angiogenesis to promote tumor growth. Blocking CCL5/VEGF signaling—through gene knockout, or the CCR5 inhibitor maraviroc—significantly enhances the antitumor efficacy of CAR‑T therapy (the diagram was created in Biorender).
Shishuo Sun +15 more
wiley +1 more source

